Precision medicine is growing more popular, and it is defined as an evolving approach to disease treatment and prevention that considers individual heterogeneity in genes, environment, and lifestyle. Big data, genomics, and other “omics” such as metabolomics, proteomics, and transcriptomics could make the promise of personalized medicine a reality in the not-too-distant future. Precision diabetes research is progressing at a breakneck pace. While it is still too early to declare that we have arrived at a point where every diabetic patient can receive a personalized treatment, we are beginning to recognize that one size does not fit all.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States